Wealth Enhancement Trust Services, Inc.
Position in CRSP — CRISPR Therapeutics AG
CIK 2067696
SIOUX FALLS, SD
Position in CRSP
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,793,929
-$54,308 QoQ
Shares Held
32,892
-15.3% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#119
of 505 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wealth Enhancement Trust Services, Inc. holds $2,277,045 across 71 Biotechnology names. CRSP ranks #1 (78.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
This page
|
32,892 | $1,793,929 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306 | $151,999 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
148 | $92,283 | |
| 4 | INCY |
Incyte Corp
|
403 | $45,683 | |
| 5 | IOVA |
Iovance Biotherapeutics, Inc.
|
9,404 | $39,120 | |
| 6 | RPRX |
Royalty Pharma plc
|
403 | $22,595 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
450 | $15,025 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
59 | $14,217 |
All Filings in CRSP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,793,929 | 32,892 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,848,237 | 38,853 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $2,032,207 | 38,753 | Shares | Sole | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||